CLINICAL_TRIALS
trial_result
· 2016-08-03
Clinical Trial Update: Dinaciclib in Treating Patients With Stage III-IV Melanoma [Phase 1, Phase 2]
Summary
A Phase 1/2 clinical trial of dinaciclib in patients with stage III-IV melanoma has been terminated; results were posted in 2016.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: National Cancer Institute (NCI) | Conditions: Stage IIIB Melanoma, Stage IIIC Melanoma | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2016-08-03